Conversion From Mycophenolate Mofetil to Mycophenolate Sodium in Renal Transplant
Status:
Completed
Trial end date:
2008-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the safety and the tolerability of the substitution
of mycophenolate mofetil for enteric-coated mycophenolate sodium in a population of stable
renal transplant patients in Brazil, in a treatment regimen of immunosuppressants with
tacrolimus and mycophenolate mofetil.